Athira Pharma Inc
Change company Symbol lookup
Select an option...
ATHA Athira Pharma Inc
TPGS TPG Pace Solutions Corp
SP SP Plus Corp
RDW Redwire Corp
BCAUY Brilliance China Automotive Holdings Ltd
RBC Regal Beloit Corp
WTRG Essential Utilities Inc
GRX Gabelli Healthcare & WellnessRx Trust
MILEW Metromile Inc *W EXP 02/09/2026
BRP BRP Group Inc
Go

Health Care : Pharmaceuticals |
Company profile

Athira Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The Company’s pipeline is built from its drug discovery platform (ATH) platform, and consists of a series of small molecules that are designed to target either the central nervous system (CNS), by crossing the blood brain barrier (BBB), or the peripheral nervous system. The ATH platform utilizes proprietary technology to target and enhance the activity of a vital neuronal growth factor that promotes neuronal health and regeneration. The Company is developing ATH-1017, for the treatment of neurodegenerative disorders, with an initial focus on Alzheimer’s disease (AD). ATH-1017 is designed to enhance neuronal health and promote regeneration, thereby improving symptoms in cognitively impaired subjects.

Price
Delayed
$9.74
Day's Change
-0.20 (-2.01%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.95
Day's Low
9.70
Volume
(Light)

Today's volume of 37,434 shares is on pace to be much lighter than ATHA's 10-day average volume of 345,409 shares.

37,434
  • Prev Close
    9.94
  • Today's Open
    9.92
  • Day's Range
    9.70-9.95
  • Avg Vol (10-day)
    345.4K
  • Last (time)
    10:45a ET 09/24/21
  • Last (size)
    100
  • 52-Wk Range
    8.88 - 34.79
    LowHigh
  • (12/31/20 - 08/17/21)
    9.68%
  • 85.8%
  • Market Cap
    364.0M
  • Shares Outstanding
    37.3M
  • -1.11
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 65.88
  • (% of float 08/31/21)
    3.49

Latest News

August 29, 2021
9:16 am ET
Newsfile
August 27, 2021
6:37 pm ET
Newsfile
August 25, 2021
6:19 pm ET
Newsfile
August 24, 2021
7:55 pm ET
Accesswire
3:33 pm ET
Accesswire
11:00 am ET
BusinessWire
10:19 am ET
Newsfile
9:38 am ET
Newsfile
1:11 am ET
Accesswire
August 23, 2021
11:26 pm ET
Globe Newswire
7:04 pm ET
Newsfile
2:43 pm ET
BusinessWire
2:22 pm ET
Accesswire
12:30 pm ET
Accesswire
11:31 am ET
Accesswire
11:00 am ET
Accesswire
11:00 am ET
Globe Newswire
9:12 am ET
Newsfile
9:10 am ET
Accesswire
7:30 am ET
Globe Newswire
6:36 am ET
Newsfile
2:02 am ET
BusinessWire
August 22, 2021
6:31 pm ET
Newsfile
8:28 am ET
Newsfile
8:27 am ET
Globe Newswire
August 21, 2021
1:57 pm ET
Globe Newswire
11:51 am ET
Globe Newswire
9:03 am ET
PR Newswire
August 20, 2021
10:50 pm ET
BusinessWire
7:13 pm ET
Accesswire
6:25 pm ET
Newsfile
4:57 pm ET
Globe Newswire
3:00 pm ET
Accesswire
2:14 pm ET
Globe Newswire
1:12 pm ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.